- Home
- LILAK vs NEO Comparison
LILAK vs NEO Comparison
Compare LILAK & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILAK
- NEO
- Stock Information
- Founded
- LILAK 2017
- NEO 2001
- Country
- LILAK Bermuda
- NEO United States
- Employees
- LILAK N/A
- NEO N/A
- Industry
- LILAK Cable & Other Pay Television Services
- NEO Precision Instruments
- Sector
- LILAK Telecommunications
- NEO Health Care
- Exchange
- LILAK Nasdaq
- NEO Nasdaq
- Market Cap
- LILAK 1.1B
- NEO 1.1B
- IPO Year
- LILAK N/A
- NEO 1999
- Fundamental
- Price
- LILAK $8.44
- NEO $9.10
- Analyst Decision
- LILAK Hold
- NEO Buy
- Analyst Count
- LILAK 2
- NEO 10
- Target Price
- LILAK $7.85
- NEO $12.56
- AVG Volume (30 Days)
- LILAK 1.1M
- NEO 2.7M
- Earning Date
- LILAK 11-05-2025
- NEO 11-04-2025
- Dividend Yield
- LILAK N/A
- NEO N/A
- EPS Growth
- LILAK N/A
- NEO N/A
- EPS
- LILAK N/A
- NEO N/A
- Revenue
- LILAK $4,409,700,000.00
- NEO $689,189,000.00
- Revenue This Year
- LILAK $1.37
- NEO $10.40
- Revenue Next Year
- LILAK N/A
- NEO $10.11
- P/E Ratio
- LILAK N/A
- NEO N/A
- Revenue Growth
- LILAK N/A
- NEO 9.70
- 52 Week Low
- LILAK $4.23
- NEO $4.72
- 52 Week High
- LILAK $10.67
- NEO $19.12
- Technical
- Relative Strength Index (RSI)
- LILAK 60.41
- NEO 67.00
- Support Level
- LILAK $8.24
- NEO $7.56
- Resistance Level
- LILAK $8.58
- NEO $8.01
- Average True Range (ATR)
- LILAK 0.24
- NEO 0.42
- MACD
- LILAK -0.00
- NEO 0.04
- Stochastic Oscillator
- LILAK 86.14
- NEO 95.80
About LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.